Our purpose is to enable and accelerate the field of proteomics by providing a platform of products and services, developed with key opinion leaders (KOLs), that are deployed across major biopharmaceutical companies and leading clinical and academic institutions, to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. […]

We are a biotechnology company focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. Our approach activates Vg9Vd2 T cells, a specific and relatively abundant gamma-delta effector T cell subset, upon cross-linking to a selected tumor target by our bispecific […]

Alignment is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors. We deliver this experience through our Medicare Advantage plans, which are customized to meet the needs of individual seniors across the United States.  We created Alignment based on the frustrating experiences we had when our parents and other loved ones needed […]

(Note: This is a blank-check company or SPAC IPO of common stock – and NOT units. Most SPAC IPOs are unit offerings.) We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare industry, […]

We intend to focus our search on companies with favorable growth prospects and attractive returns on invested capital. Jay R. Bloom and Dean C. Kehler, our co-chairmen and co-CEOs, are managing partners of Trimaran Capital Partners, which they co-founded in 1998.

We intend to focus on companies that have an aggregate enterprise value of approximately $500 million to $5 billion or more, are North American- or Western European-based, have excellent management teams, have a robust outlook for long-term growth, and would benefit from access to capital to fund organic growth or acquisitions. As our name indicates, this is the […]

We intend to focus our search on land and resource holding companies.

We intend to focus our search on industrial, transportation & mobility, consumer and retail sectors, where our management team can capitalize on its decades of strategic experience to identify, acquire and operate an attractive target and drive superior shareholder value creation. Robert Nardelli is our CEO and the chairman of our board of directors. He began […]

We intend to concentrate our efforts on identifying a target business that is exiting the restructuring process or that has transient current ownership, with particular emphasis on businesses that have strong management teams, realigned capital structures, positive cash flows prospects, and a clear and well-defined pathway for growing profitably over the long-term. In addition, we […]

(Note: This is an IPO of American Depositary Shares. Each ADS represents two ordinary shares, the prospectus says.) Hywin is the third-largest third-party wealth management service provider in China, with a 7.5% market share in terms of 2019 transaction value, according to CIC. According to the same source, among the five largest industry participants in […]